The global Digital PCR (dPCR) and Real-time PCR (qPCR) market is projected to grow from $10.0 billion in 2024 to $14.8 billion by 2029, at a CAGR of 8.1% during the forecast period. Market growth is fueled by the increasing adoption of PCR technologies in point-of-care diagnostics, continuous technological advancements, and the rising importance of PCR in biomarker discovery.
Clinical Applications Segment to Register Highest Growth
By application, the clinical segment is projected to account for the largest share of the market during the forecast period. The increasing use of PCR technologies in disease diagnosis, particularly for infectious diseases and cancer, is a key growth driver.
The Asia Pacific region is expected to register the highest growth rate in the Digital PCR (dPCR) and Real-time PCR (qPCR) market during the forecast period. Growth in this region is driven by increasing incidences of infectious diseases, rising investments by biopharmaceutical companies and contract manufacturing organizations (CMOs), and a growing focus on strengthening healthcare infrastructure.
Original reporting: KTBS 3 (Shreveport) — read the source article.
